Science

first-in-class small molecules promoting neuroprotection and remyelination.
Read more

Focus

Rare ophthalmological conditions: optic neuritis and neuromyelitis optica.
Read more

News

Si tuviéramos Sand Hill Road: Entrevista a Pablo Villoslada, CSO de Bionure